165 related articles for article (PubMed ID: 24911240)
21. Rapid tumor formation of human T-cell leukemia virus type 1-infected cell lines in novel NOD-SCID/gammac(null) mice: suppression by an inhibitor against NF-kappaB.
Dewan MZ; Terashima K; Taruishi M; Hasegawa H; Ito M; Tanaka Y; Mori N; Sata T; Koyanagi Y; Maeda M; Kubuki Y; Okayama A; Fujii M; Yamamoto N
J Virol; 2003 May; 77(9):5286-94. PubMed ID: 12692230
[TBL] [Abstract][Full Text] [Related]
22. Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma.
Blechacz B; Splinter PL; Greiner S; Myers R; Peng KW; Federspiel MJ; Russell SJ; LaRusso NF
Hepatology; 2006 Dec; 44(6):1465-77. PubMed ID: 17133484
[TBL] [Abstract][Full Text] [Related]
23. Control of Human T-Cell Leukemia Virus Type 1 (HTLV-1) Infection by Eliminating Envelope Protein-Positive Cells with Recombinant Vesicular Stomatitis Viruses Encoding HTLV-1 Primary Receptor.
Tezuka K; Okuma K; Kuramitsu M; Matsuoka S; Tanaka R; Tanaka Y; Hamaguchi I
J Virol; 2018 Feb; 92(4):. PubMed ID: 29212930
[TBL] [Abstract][Full Text] [Related]
24. Type I interferon-sensitive recombinant newcastle disease virus for oncolytic virotherapy.
Elankumaran S; Chavan V; Qiao D; Shobana R; Moorkanat G; Biswas M; Samal SK
J Virol; 2010 Apr; 84(8):3835-44. PubMed ID: 20147405
[TBL] [Abstract][Full Text] [Related]
25. Recombinant measles virus induces cytolysis of cutaneous T-cell lymphoma in vitro and in vivo.
Künzi V; Oberholzer PA; Heinzerling L; Dummer R; Naim HY
J Invest Dermatol; 2006 Nov; 126(11):2525-32. PubMed ID: 16960554
[TBL] [Abstract][Full Text] [Related]
26. The MyD88 pathway in plasmacytoid and CD4+ dendritic cells primarily triggers type I IFN production against measles virus in a mouse infection model.
Takaki H; Takeda M; Tahara M; Shingai M; Oshiumi H; Matsumoto M; Seya T
J Immunol; 2013 Nov; 191(9):4740-7. PubMed ID: 24078691
[TBL] [Abstract][Full Text] [Related]
27. Mesenchymal stem cell carriers protect oncolytic measles viruses from antibody neutralization in an orthotopic ovarian cancer therapy model.
Mader EK; Maeyama Y; Lin Y; Butler GW; Russell HM; Galanis E; Russell SJ; Dietz AB; Peng KW
Clin Cancer Res; 2009 Dec; 15(23):7246-55. PubMed ID: 19934299
[TBL] [Abstract][Full Text] [Related]
28. Stromal cell-mediated suppression of human T-cell leukemia virus type 1 expression in vitro and in vivo by type I interferon.
Kinpara S; Hasegawa A; Utsunomiya A; Nishitsuji H; Furukawa H; Masuda T; Kannagi M
J Virol; 2009 May; 83(10):5101-8. PubMed ID: 19264779
[TBL] [Abstract][Full Text] [Related]
29. Thymoquinone enhances the anticancer activity of doxorubicin against adult T-cell leukemia in vitro and in vivo through ROS-dependent mechanisms.
Fatfat M; Fakhoury I; Habli Z; Mismar R; Gali-Muhtasib H
Life Sci; 2019 Sep; 232():116628. PubMed ID: 31278946
[TBL] [Abstract][Full Text] [Related]
30. [New treatment strategy for adult T-cell leukemia targeting for anti-tumor immunity and a longevity gene-encoded protein].
Kozako T
Yakugaku Zasshi; 2011; 131(7):1061-72. PubMed ID: 21720136
[TBL] [Abstract][Full Text] [Related]
31. Thymoquinone synergizes with arsenic and interferon alpha to target human T-cell leukemia/lymphoma.
Houssein M; Fatfat M; Habli Z; Ghazal N; Moodad S; Khalife H; Khalil M; Gali-Muhtasib H
Life Sci; 2020 Jun; 251():117639. PubMed ID: 32272181
[TBL] [Abstract][Full Text] [Related]
32. Development of a Unique T Cell Receptor Gene-Transferred Tax-Redirected T Cell Immunotherapy for Adult T Cell Leukemia.
Kawamura K; Tanaka Y; Nakasone H; Ishihara Y; Kako S; Kobayashi S; Tanaka Y; Ohmori T; Uchimaru K; Okamoto S; Mineno J; Shiku H; Nishimura S; Kanda Y
Biol Blood Marrow Transplant; 2020 Aug; 26(8):1377-1385. PubMed ID: 32311478
[TBL] [Abstract][Full Text] [Related]
33. Activating Fc receptors are required for antitumor efficacy of the antibodies directed toward CD25 in a murine model of adult t-cell leukemia.
Zhang M; Zhang Z; Garmestani K; Goldman CK; Ravetch JV; Brechbiel MW; Carrasquillo JA; Waldmann TA
Cancer Res; 2004 Aug; 64(16):5825-9. PubMed ID: 15313926
[TBL] [Abstract][Full Text] [Related]
34. Mouse models of human T lymphotropic virus type-1-associated adult T-cell leukemia/lymphoma.
Zimmerman B; Niewiesk S; Lairmore MD
Vet Pathol; 2010 Jul; 47(4):677-89. PubMed ID: 20442421
[TBL] [Abstract][Full Text] [Related]
35. Antiviral and antiproliferative activities of recombinant human interferon alpha 2, beta and gamma on HTLV-I and ATL cells in vitro.
Koyama Y; Tanaka Y; Oda S; Yamashita U; Eto S
J UOEH; 1990 Jun; 12(2):149-61. PubMed ID: 2117774
[TBL] [Abstract][Full Text] [Related]
36. Measles to the Rescue: A Review of Oncolytic Measles Virus.
Aref S; Bailey K; Fielding A
Viruses; 2016 Oct; 8(10):. PubMed ID: 27782084
[TBL] [Abstract][Full Text] [Related]
37. Cell death induced by dorsomorphin in adult T-cell leukemia/lymphoma is AMPK-independent.
Aikawa A; Kozako T; Uchida Y; Yoshimitsu M; Ishitsuka K; Ohsugi T; Honda SI
FEBS J; 2020 Sep; 287(18):4005-4015. PubMed ID: 32027454
[TBL] [Abstract][Full Text] [Related]
38. Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-kappaB, as a strategy for chemoprevention and therapy of adult T-cell leukemia.
Watanabe M; Ohsugi T; Shoda M; Ishida T; Aizawa S; Maruyama-Nagai M; Utsunomiya A; Koga S; Yamada Y; Kamihira S; Okayama A; Kikuchi H; Uozumi K; Yamaguchi K; Higashihara M; Umezawa K; Watanabe T; Horie R
Blood; 2005 Oct; 106(7):2462-71. PubMed ID: 15956280
[TBL] [Abstract][Full Text] [Related]
39. Engineered measles virus as a novel oncolytic therapy against prostate cancer.
Msaouel P; Iankov ID; Allen C; Morris JC; von Messling V; Cattaneo R; Koutsilieris M; Russell SJ; Galanis E
Prostate; 2009 Jan; 69(1):82-91. PubMed ID: 18973133
[TBL] [Abstract][Full Text] [Related]
40. Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme.
Liu C; Sarkaria JN; Petell CA; Paraskevakou G; Zollman PJ; Schroeder M; Carlson B; Decker PA; Wu W; James CD; Russell SJ; Galanis E
Clin Cancer Res; 2007 Dec; 13(23):7155-65. PubMed ID: 18056196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
